Cargando…

Strategies for Continued Successful Treatment in Patients with  Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents

INTRODUCTION: Alzheimer’s disease (AD) is the most common cause of dementia, characterized by a progressive decline in cognition and function. Current treatment options for AD include the cholines-terase inhibitors (ChEIs) donepezil, galantamine, and rivastigmine, as well as the N-methyl-D-aspartate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blesa, Rafael, Toriyama, Kazuhiro, Ueda, Kengo, Knox, Sean, Grossberg, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142408/ https://www.ncbi.nlm.nih.gov/pubmed/29895249 http://dx.doi.org/10.2174/1567205015666180613112040

Ejemplares similares

Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
por: Kristensen, Lars Erik, et al.
Publicado: (2018)

Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan
por: Ueda, Kengo, et al.
Publicado: (2019)

Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease
por: Wang, Liao-Yao, et al.
Publicado: (2020)

Promising Treatment Options for Axial Spondyloarthritis: An Overview of Experimental Pharmacological Agents
por: Tahir, Hasan, et al.
Publicado: (2021)

Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
por: Soares, Ricardo O. S., et al.
Publicado: (2019)

Managing insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon
por: Schwartz, Thomas L, et al.
Publicado: (2013)

COVID-19: general overview, pharmacological options and ventilatory support strategies
por: Menzella, Francesco, et al.
Publicado: (2020)

Developmental pharmacology: overview.
por: Fouts, J R
Publicado: (1976)

Pharmacological Overview of Galactogogues
por: Penagos Tabares, Felipe, et al.
Publicado: (2014)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease
por: Ye, Xian-wen, et al.
Publicado: (2022)

Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines
por: Xiao, Yinan, et al.
Publicado: (2020)

An Overview of Nanomaterial Applications in Pharmacology
por: Roy, Madhura, et al.
Publicado: (2023)

An overview of clinical decision support systems: benefits, risks, and strategies for success
por: Sutton, Reed T., et al.
Publicado: (2020)

An Overview of Biofilm Formation–Combating Strategies and Mechanisms of Action of Antibiofilm Agents
por: Asma, Syeda Tasmia, et al.
Publicado: (2022)

Alternative Pharmacological Strategies for the Treatment of Alzheimer’s Disease: Focus on Neuromodulator Function
por: Cunliffe, Grace, et al.
Publicado: (2022)

Acetylcholine Neuromodulation in Normal and Abnormal Learning and Memory: Vigilance Control in Waking, Sleep, Autism, Amnesia and Alzheimer’s Disease
por: Grossberg, Stephen
Publicado: (2017)

Circadian Rhythm Disturbances in Patients with Alzheimer's Disease: A Review
por: Weldemichael, Dawit A., et al.
Publicado: (2010)

How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview
por: Empeslidis, Theodoros, et al.
Publicado: (2019)

Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks
por: Peng, Yong, et al.
Publicado: (2023)

New therapeutic strategy for Alzheimer's disease using antidiabetes agents
por: Yokono, Koichi
Publicado: (2013)

Chemistry and pharmacology of Bidens pilosa: an overview
por: Xuan, Tran Dang, et al.
Publicado: (2016)

Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia
por: Lipsy, Robert J.
Publicado: (2003)

The Pharmacological Implications of Flavopiridol: An Updated Overview
por: Joshi, Hemant, et al.
Publicado: (2023)

Advances in Alzheimer’s disease’s pharmacological treatment
por: Conti Filho, Carlos Elias, et al.
Publicado: (2023)

Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer’s Disease
por: Peña-Altamira, Emiliano, et al.
Publicado: (2017)

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
por: Poor, Saghar Rabiei, et al.
Publicado: (2021)

When aging switches on Alzheimer’s
por: Dong, Yue, et al.
Publicado: (2021)

Pharmacological immunosuppressive agents.
por: Salaman, J. R.
Publicado: (1981)

Pharmacological Overview of the BGP-15 Chemical Agent as a New Drug Candidate for the Treatment of Symptoms of Metabolic Syndrome
por: Pető, Ágota, et al.
Publicado: (2020)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Thomas, Stuart J, et al.
Publicado: (2009)

An overview of biomarkers in Alzheimer’s disease
por: Wattamwar, Pandurang R, et al.
Publicado: (2010)

Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies
por: Rygiel, Katarzyna
Publicado: (2016)

Pharmacological switch in Aβ-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury
por: Matsumoto, Misaki, et al.
Publicado: (2008)

Present Algorithms and Future Treatments for Alzheimer’s Disease
por: Grossberg, George T., et al.
Publicado: (2019)

A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer’s disease
por: Deardorff, William James, et al.
Publicado: (2016)

Overview: viral agents and cancer.
por: Mueller, N
Publicado: (1995)

Cognitive Intervention As an Early Non-pharmacological Strategy in Alzheimer's Disease: A Translational Perspective
por: Gehres, Sarah W., et al.
Publicado: (2016)

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019)

Pharmacological and clinical overview of cloperastine in treatment of cough
por: Catania, Maria Antonietta, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_uq3e5r91p63cgbr53ou8um6sl9